Long non coding RNAs (lncRNAs) are dysregulated in malignant pleural mesothelioma (MPM)

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wright, Casey M ^a   Kirschner, Michaela B ^a   Cheng, Yuen Yee ^a   O'Byrne, Kenneth J ^b   Gray, Steven G ^b   Schelch, Karin ^f   Hoda, Mir Alireza ^f   Klebe, Sonja ^c   McCaughan, Brian ^d,e   Van Zandwijk, Nico ^a   Reid, Glen ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LONG UNTRANSLATED RNA;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INDUCTION CHEMOTHERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PLEURA MESOTHELIOMA; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION;

EID: 84901614450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070940     Document Type: Article

References (53)

1. Henderson DW, Rodelsperger K, Woitowitz HJ, Leigh J (2004) After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. Pathology 36: 517-550.
2. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, et al. (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21: 2636-2644.
3. Weder W, Stahel RA, Bernhard J, Bodis S, Vogt P, et al. (2007) Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18: 1196-1202.
4. Wang KC, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43: 904-914.
5. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146: 353-358.
6. Gutschner T, Diederichs S (2012) The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 9: 703-719.
7. Schmidt LH, Spieker T, Koschmieder S, Humberg J, Jungen D, et al. (2011) The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol 6: 1984-1992.
8. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, et al. (2010) MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 584: 4575-4580.
9. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, et al. (2010) The nuclearretained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 39: 925-938.
10. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, et al. (2010) Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076.
11. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, et al. (2011) Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 18: 1243-1250.
12. Li D, Feng J, Wu T, Wang Y, Sun Y, et al. (2013) Long Intergenic Noncoding RNA HOTAIR Is Overexpressed and Regulates PTEN Methylation in Laryngeal Squamous Cell Carcinoma. Am J Pathol 182: 64-70.
13. Relan V, Morrison L, Parsonson K, Clarke BE, Duhig EE, et al. (2013) Phenotypes and karyotypes of human malignant mesothelioma cell lines. PLoS One 8: e58132.
14. Hoda MA, Munzker J, Ghanim B, Schelch K, Klikovits T, et al. (2012) Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells. Br J Cancer 107: 1978-1986.
15. Kryeziu K, Jungwirth U, Hoda MA, Ferk F, Knasmuller S, et al. (2013) Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double strand break repair. Mol Cancer Ther.
16. Melotti A, Daga A, Marubbi D, Zunino A, Mutti L, et al. (2010) In vitro and in vivo characterization of highly purified human mesothelioma derived cells. BMC Cancer 10: 54.
17. Smythe WR, Kaiser LR, Hwang HC, Amin KM, Pilewski JM, et al. (1994) Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thorac Surg 57: 1395-1401.
18. Kao SC, Lee K, Armstrong NJ, Clarke S, Vardy J, et al. (2011) Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology 43: 128-132.
19. Pfaffl MW (2001) A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29: e45.
20. Simon R, Lam A, Li MC, Ngan M, Menenzes S, et al. (2007) Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 3: 11-17.
21. Huang DW, Sherman BT, Lempicki RA (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocols 4: 44-57.
22. Engstrom PG, Suzuki H, Ninomiya N, Akalin A, Sessa L, et al. (2006) Complex Loci in human and mouse genomes. PLoS Genet 2: e47.
23. Dinger ME, Amaral PP, Mercer TR, Pang KC, Bruce SJ, et al. (2008) Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res 18: 1433-1445.
24. Gordon GJ (2005) Transcriptional profiling of mesothelioma using microarrays. Lung Cancer 49 Suppl 1: S99-S103.
25. Gordon GJ, Rockwell GN, Jensen RV, Rheinwald JG, Glickman JN, et al. (2005) Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am J Pathol 166: 1827-1840.
26. Crispi S, Calogero RA, Santini M, Mellone P, Vincenzi B, et al. (2009) Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target. PLoS ONE 4: e7016.
27. Kettunen E, Nissen AM, Ollikainen T, Taavitsainen M, Tapper J, et al. (2001) Gene expression profiling of malignant mesothelioma cell lines: cDNA array study. Int J Cancer 91: 492-496.
28. Cui Z, Ren S, Lu J, Wang F, Xu W, et al. (2012) The prostate cancer-upregulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol Oncol.
29. Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, et al. (2011) The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res 71: 3852-3862.
30. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, et al. (2011) Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 71: 6320-6326.
31. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, et al. (2009) An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell 33: 717-726.
32. Chen L-L, Carmichael GG (2009) Altered Nuclear Retention of mRNAs Containing Inverted Repeats in Human Embryonic Stem Cells: Functional Role of a Nuclear Noncoding RNA. Mol Cell 35: 467-478.
33. Kau TR, Way JC, Silver PA (2004) Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 4: 106-117.
34. Brunner AH, Riss P, Heinze G, Meltzow E, Brustmann H (2011) Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53. Int J Gynecol Pathol 30: 569-575.
35. Laury AR, Hornick JL, Perets R, Krane JF, Corson J, et al. (2010) PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol 34: 627-635.
36. Camargo MC, Stayner LT, Straif K, Reina M, Al-Alem U, et al. (2011) Occupational exposure to asbestos and ovarian cancer: a meta-analysis. Environ Health Perspect 119: 1211-1217.
37. Mironov O, Sala E, Mironov S, Pannu H, Chi DS, et al. (2011) Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery. J Gynecol Oncol 22: 260-268.
38. Mahmoudi S, Henriksson S, Corcoran M, Mendez-Vidal C, Wiman KG, et al. (2009) Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol Cell 33: 462-471.
39. Kimura T, Jiang S, Nishizawa M, Yoshigai E, Hashimoto I, et al. (2012) Stabilization of human interferon-alpha1 mRNA by its antisense RNA. Cell Mol Life Sci.
40. Iadevaia V, Zhang Z, Jan E, Proud CG (2012) mTOR signaling regulates the processing of pre-rRNA in human cells. Nucleic Acids Res 40: 2527-2539.
41. Fischer JR, Ohnmacht U, Rieger N, Zemaitis M, Stoffregen C, et al. (2006) Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma. Lung Cancer 54: 109-116.
42. Bowman RV, Wright CM, Davidson MR, Francis SM, Yang IA, et al. (2009) Epigenomic targets for the treatment of respiratory disease. Expert Opin Ther Targets 13: 625-640.
43. Sun X, Wei L, Liden J, Hui G, Dahlman-Wright K, et al. (2005) Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling. J Pathol 207: 91-101.
44. Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, et al. (2011) microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30: 4750-4756.
45. Sumazin P, Yang X, Chiu HS, Chung WJ, Iyer A, et al. (2011) An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 147: 370-381.
46. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, et al. (2010) A codingindependent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465: 1033-1038.
47. Shappell SB (2008) Clinical utility of prostate carcinoma molecular diagnostic tests. Rev Urol 10: 44-69.
48. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, et al. (2007) Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132: 330-342.
49. Ji P, Diederichs S, Wang W, Boing S, Metzger R, et al. (2003) MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22: 8031-8041.
50. Chisholm KM, Wan Y, Li R, Montgomery KD, Chang HY, et al. (2012) Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma. PLoS One 7: e47998.
51. Nie Y, Liu X, Qu S, Song E, Zou H, et al. (2013) Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci.
52. Tsang WP, Wong TW, Cheung AH, Co CN, Kwok TT (2007) Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. RNA 13: 890-898.
53. Klebe S, Nurminen M, Leigh J, Henderson DW (2009) Diagnosis of epithelial mesothelioma using tree-based regression analysis and a minimal panel of antibodies. Pathology 41: 140-148.